Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologicsAlan Menter, Craig A. Elmets, Boni E. Elewski et al.|Journal of the American Academy of Dermatology|2019Cited by 917
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbiditiesCraig A. Elmets, Alan Menter, Craig L. Leonardi et al.|Journal of the American Academy of Dermatology|2019Cited by 484
Deucravacitinib: A Novel TYK2 Inhibitor for the Treatment of Moderate-to-Severe PsoriasisPaige Kingston, April W. Armstrong, Andrew Blauvelt et al.|Journal of Psoriasis and Psoriatic Arthritis|2023Cited by 25
JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patientsNeda Shahriari, Mona Shahriari, Bruce Strober|JAAD Case Reports|2023Cited by 11
Upadacitinib for the treatment of psoriasiform and spongiotic dermatitis: A multicenter case seriesNeda Shahriari, Mona Shahriari, Bruce Strober|JAAD Case Reports|2024Cited by 11